Abstract
IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenibin relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have